Retatrutide 10mg

Retatrutide is the most advanced metabolic research peptide currently in clinical development — a triple-receptor agonist simultaneously targeting GLP-1, GIP, and glucagon receptors. Where single-agonist compounds like Semaglutide work on one pathway, Retatrutide hits all three, producing a synergistic metabolic effect that has generated some of the most significant results in modern peptide clinical research.

What researchers are studying Retatrutide for:

• Triple-receptor agonism: GLP-1, GIP, and glucagon pathways simultaneously
• Metabolic regulation and body composition research
• Insulin sensitivity and glucose metabolism
• Energy expenditure via glucagon receptor activity
• Appetite and satiety signalling via GLP-1 and GIP

Why triple-agonism matters:

Each receptor contributes differently to the overall effect. GLP-1 drives satiety and insulin secretion. GIP enhances GLP-1 activity and supports fat metabolism. Glucagon increases energy expenditure and drives fat mobilization. Together, the combined signal is significantly more potent than any single-receptor compound — Phase 2 trial data showed up to 24% body weight reduction, the highest number ever recorded in a metabolic peptide trial at that stage.

Product Details:

• Quantity: 10mg lyophilized powder
• Purity: ≥99% (HPLC verified)
• Form: Lyophilized powder in sealed vial
• Storage: Freeze at -20°C. Stable 24+ months lyophilized. Refrigerate after reconstitution.
• Reconstitution: Bacteriostatic water required (available separately)

✓ Third-party tested by JanoShik  |  ✓ Ships from Canada  |  ✓ COA available on request  |  ✓ Ships within 24 hours of payment

This product is intended for research purposes only and is not approved for human use. Not for human or veterinary consumption. For laboratory and research use only. HelixCoreLabs makes no medical claims regarding this product.